Internal Medicine, Medical Oncology · Philadelphia, PA
NPI
1619139235
Since 2008
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
333 Cottman Ave
Philadelphia, PA, 19111
Phone (215) 728-6900
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
381 services
Medicare patients, 2024
112
Average age 73
Drug cost, 2024
$1.8M
462 prescriptions
Company payments, 2025
$4,183
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica R Bauman was code 99215 (office e&m - established), 154 times for 49 patients. In total Jessica R Bauman billed 381 services in 11 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 154 | 49 | $111.14 | $17K |
| 99214 Office E&M - Established | Facility | 144 | 64 | $75.81 | $11K |
| 99205 Office E&M - New | Facility | 15 | 15 | $138.61 | $2,079 |
By year: 2022 $39K for 448 services; 2023 $30K for 323 services; 2024 $35K for 381 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jessica R Bauman prescribed most often to Medicare patients was Levothyroxine Sodium, with 55 prescriptions and refills. In total Jessica R Bauman wrote 462 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 55 | 142 | 18 | $697 |
| Oxycodone Hcl Generic | 42 | 42 | Under 11 | $447 |
| Lenvima Lenvatinib Mesylate | 24 | 26 | Under 11 | $579K |
| Retevmo Selpercatinib | 20 | 20 | Under 11 | $279K |
| Tagrisso Osimertinib Mesylate | 15 | 15 | Under 11 | $256K |
| Morphine Sulfate Er Morphine Sulfate | 14 | 14 | Under 11 | $211 |
| Synthroid Levothyroxine Sodium | 13 | 39 | Under 11 | $1,660 |
| Vitrakvi Larotrectinib Sulfate | 13 | 13 | Under 11 | $514K |
| Ondansetron Hcl Generic | 12 | 12 | Under 11 | $294 |
| Sorafenib Sorafenib Tosylate | 11 | 11 | Under 11 | $40K |
| Cyclobenzaprine Hcl Generic | 11 | 11 | Under 11 | $14.46 |
| Eliquis Apixaban | 11 | 11 | Under 11 | $7,088 |
Brand drugs: - claims; generic drugs: 334 claims; opioid claims: 71.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica R Bauman $4,183 ($4,183 in general payments such as food, travel and fees) from 6 companies. The largest payer was Aveo Pharmaceuticals, Inc. with $2,420.
| Company | Payments | Amount |
|---|---|---|
| Aveo Pharmaceuticals, Inc. | 1 | $2,420 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $1,763 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.